Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Emergent Biosolutions (NY: EBS )

52.39 USD -1.45 (-2.69%)
Official Closing Price Updated: 7:00 PM EDT, Sep 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 365,502
Open 53.61
Bid (Size) 52.45 (4)
Ask (Size) 53.09 (6)
Prev. Close 53.84
Today's Range 52.36 - 53.75
52wk Range 52.36 - 127.20
Shares Outstanding 53,700,729
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Emergent BioSolutions Secures Multi-Year Development and Manufacturing Agreement with Providence Therapeutics for its mRNA COVID-19 Vaccine Candidate, PTX-COVID19-B
From GlobeNewswire News Releases
NYSE: EBS Investor Notice: Lawsuit against Emergent BioSolutions Inc announced by the Shareholders Foundation
From GlobeNewswire News Releases

Performance

YTD
-43.73%
-43.73%
1 Month
-16.64%
-16.64%
3 Month
-16.42%
-16.42%
6 Month
-43.56%
-43.56%
1 Year
-48.45%
-48.45%

More News

Read More
Shuman, Glenn & Stecker Investigates Emergent BioSolutions, Inc.
From Business Wire News Releases
Emergent BioSolutions’ COVID-19 Human Immune Globulin Product Candidate to be Evaluated in NIH-Sponsored Phase 3 Clinical Trial (INSIGHT-012) of Hyperimmune Intravenous Immunoglobulin for Outpatient T
From GlobeNewswire News Releases
Emergent BioSolutions to Participate in Investor Conferences
From GlobeNewswire News Releases
EBS Long Term Investor Alert: Did You Acquire (EBS) Before April 24, 2020? – Johnson Fistel Continues its Investigation
From GlobeNewswire News Releases
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Emergent BioSolutions, Peloton, and Vroom on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
EBS Long Term Investor Alert: Did You Acquire (EBS) Before April 24, 2020? - Contact Johnson Fistel Regarding Investigation
From GlobeNewswire News Releases
Emergent BioSolutions Reports Financial Results For Second Quarter 2021
From GlobeNewswire News Releases
How The Parts Add Up: IJH Targets $308
Tags ETFs
From ETF Channel
Emergent Secures Contract To Manufacture Providence Therapeutics' COVID-19 Vaccine Candidate
Tags General COVID/19 Coronavirus News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.